Daniele Alesini

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Orazio Caffo, Ugo De Giorgi, Lucia Fratino et al. · European Urology · 2014 · 83 citations · Full text

Medicine, Oncology, Urology +12

Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney

Emanuela Risi, Roberto Iacovelli, Amelia Altavilla et al. · Urology · 2013 · 82 citations

Medicine, Oncology, Pathology +14

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

Alessandra Fabi, Daniele Alesini, Enrichetta Valle et al. · The Breast · 2018 · 58 citations

Medicine, Neurology, Oncology +16

Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study

Andrea Botticelli, Roberta Caputo, Simone Scagnoli et al. · The Oncologist · 2023 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study

Alessandra Fabi, Michelino De Laurentiis, Michele Caruso et al. · Oncotarget · 2017 · 25 citations · Full text

Medicine, Oncology, Breast Oncology +6